FEMTECH MARKET OVERVIEW
FemTech refers to software, products and services, and diagnostics that use technology to improve women’s health.
About 50% of the FemTech market belong to Pregnancy & Nursing and Reproductive Health sectors, however, it is not only limited to these categories.
Other important FemTech sectors include Longevity, Healthcare, Diagnostics, Personal Care & Wellbeing, Beauty for FemTech, and PharmTech.
Problems are tackled via platforms (e.g. apps and telehealth), deep tech (e.g. AI, ML and big data), and devices (e.g. wearables, sensors, and remote patient monitoring.)
The FemTech industry can be thought of as a continuum process: pre-care → during care → post-care.
FemTech has only been around for a couple of years; however, the issues it is facing have been unresolved for decades.
Being relatively ‘young’, the FemTech Industry remains largely underfunded; however, it is predicted to grow exponentially in the coming years. The FemTech industry (and more specifically, women’s health and technology) is projected to double in size and include more areas. However, for that to happen, it will have to overcome various challenges.
Lack of Investment
The FemTech Industry accounts for only 1.4% of capital invested in healthcare.
Insufficient R&D Funding
Only 4% of healthcare R&D funding is targeted at women’s health.
It is hard to get public support in subjects people are less likely to talk about.
Pace of Education
Not enough is being done to debunk myths and break taboos surrounding women-related issues.
Economic hardships hinder access to high-tech products (e.g. wearable devices) for women in rural areas of the world.
Fear of an unfair ‘pink tax’ applied to products marketed to women.
Historically, fewer venture capital is invested in women-related startups.
Underestimation of Issues
When it comes to health issues, women are largely not listened to or believed; hence, lower efficiency.
As it evolved, FemTech has ceased to be a merely reproductive concept and become one that encompasses a wide range of health issues disproportionately affecting women (e.g. Alzheimer’s, immunodeficiencies or pain management solutions).
FemTech Industry Composition
FemTech Industry: At a Glance
The FemTech Industry can be divided into 14 subsectors covering all aspects of women’s health ranging from Longevity, Reproductive Health to Mental Health and Pharmtech. The report focuses on: 1,550 companies in which a total of $16 billion has been invested; 1,000 investors that have invested in more than 500 FemTech companies; 30 R&D centers; 50 top influencers. Pregnancy, Longevity, and Fertility are the three largest subsectors accounting for 48% of the entire industry.
FemTech Industry: At a Glance
FemTech Market Size, 2019-2027
Valued at $18.7B in 2019, the FemTech market is expected to grow to $60B by 2027, at a CAGR of
15.6%. Despite increased interest from investors, the industry still remains underinvested; hence, it has a huge growth potential.
The reason female healthcare has garnered so much attention in recent years is that there has been a shift in the sociocultural paradigm. Thanks to that, many topics that were previously ignored can now be openly discussed.
Increased awareness, early self-detection and better management of illnesses by women of all ages have resulted in an increase in demand for technological solutions. As of now, this demand hasn’t been fully satisfied.
FemTech Companies Regional Distribution
When it comes to FemTech companies, North America, and particularly the US, is the undisputed leader. Accounting for nearly 52% of the total number of FemTech companies, it beats other regions by a wide margin. Europe is second, at 24%, followed by Asia with 14%. The UK and Israel are the two countries with the highest number of FemTech companies in their respective regions. Asia’s undisputed leader is India which accounts for 5% of FemTech companies.
Distribution of FemTech Companies by Regions, 2021
Countries with the Largest Number of FemTech Companies, 2021
FemTech Companies by Subsectors Overview in 2021
Accounting for 21.8% of the total market, Pregnancy is the largest subsector of the FemTech Industry. It is followed by Longevity and Fertility, which account for 13.1% each.
Pregnancy & Nursing is the largest aggregated subsector, followed by Reproductive Health, and Healthcare. Together, these top 3 aggregated subsectors account for 70% of the entire FemTech market.
FemTech Companies by Product Overview, 2021
Classifying the FemTech market by product types and analyzing the companies’ distribution, we see that Services is the largest category accounting for 34% of the entire FemTech market. The other products are more or less evenly distributed. Interestingly, 91% of the companies supply one product, while only 9% of them manufacture more than one product. The most popular combinations include Device and Service, App and Device, Femcare Product and Pharm Product.
FemTech Aggregated Subsectors Funding
Comprised of General Healthcare and Women’s Cancers Treatment (about 300 companies totally), Healthcare aggregated subsector receives the highest share of the total FemTech funding — 35.6%. Being the second largest aggregated subsector by the number of companies (384), Reproductive Health is also on the second place in terms of funding (20.3%). Longevity has 18.7% of the total industry funding, having about 200 companies. Despite having 88 companies, Personal Care & Wellbeing is one of the least funded aggregated subsectors. In terms of the funding status, Seed is the most popular type, followed by M&A and Early Stage Venture.
Top Recent M&A Deals in FemTech
Major FemTech Market Development Drivers
FemTech Future Prospects
Currently, the vast majority of FemTech companies are focusing on the Fertility and Pregnancy space; however, that’s likely to change within the next decade. It is also expected that new and promising areas, such as Longevity, menopause, SexTech, therapy and breastfeeding will be experiencing rapid growth.
Here are the factors that can help determine the direction in which the industry will be headed.
By 2025, 1.1 billion women are expected to be postmenopausal. Currently, only 5% of startups are providing menopause solutions.
The service segment is expected to expand. FemTech companies that provide services, will benefit from this global trend and are likely to increase in number.
Emerging global economies will also speed up the spread of smart medical devices and wearables, including FemTech devices.
DNA testing helping women determine the likelihood of breast and cervical cancer and other genetic diseases will be increasingly available.